"Blockers"

#13031795

27 November 2025

Calcium channel blocker tablets Diltiazem/Dilzem are unavailable in German pharmacies in Munich, Bavaria, Germany, on November 27, 2025, following delivery problems with statins on the German pharmaceutical market a few weeks ago. Diltiazem is a drug used to treat heart conditions such as angina pectoris (chest pain due to insufficient oxygen supply to the heart muscle) and high blood pressure.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13031797

27 November 2025

Calcium channel blocker tablets Diltiazem/Dilzem are unavailable in German pharmacies in Munich, Bavaria, Germany, on November 27, 2025, following delivery problems with statins on the German pharmaceutical market a few weeks ago. Diltiazem is a drug used to treat heart conditions such as angina pectoris (chest pain due to insufficient oxygen supply to the heart muscle) and high blood pressure.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13031798

27 November 2025

Calcium channel blocker tablets Diltiazem/Dilzem are unavailable in German pharmacies in Munich, Bavaria, Germany, on November 27, 2025, following delivery problems with statins on the German pharmaceutical market a few weeks ago. Diltiazem is a drug used to treat heart conditions such as angina pectoris (chest pain due to insufficient oxygen supply to the heart muscle) and high blood pressure.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12485971

19 June 2025

Supporters of gender-affirming care rally at the Lutheran Church of the Reformation near the Supreme Court in Washington, D.C. on June 18, 2025 in response to the court's ruling upholding Tennessee's ban on gender-affirming care for minors. The Supreme Court ruled in a 6-3 decision in the case of U.S. v. Skrmetti that Tennessee's SB1 ban, which bars puberty blockers and hormone therapies for transgender minors, does not violate the U.S. Constitution and can remain in effect.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12485973

19 June 2025

U.S. Senator Ed Markey (D-MA) speaks at a rally supporting gender-affirming care at the Lutheran Church of the Reformation near the Supreme Court in Washington, D.C. on June 18, 2025 in response to the court's ruling upholding Tennessee's ban on gender-affirming care for minors. The Supreme Court ruled in a 6-3 decision in the case of U.S. v. Skrmetti that Tennessee's SB1 ban, which bars puberty blockers and hormone therapies for transgender minors, does not violate the US Constitution and can remain in effect.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12485974

19 June 2025

U.S. Senator Ed Markey (D-MA) speaks at a rally supporting gender-affirming care at the Lutheran Church of the Reformation near the Supreme Court in Washington, D.C. on June 18, 2025 in response to the court's ruling upholding Tennessee's ban on gender-affirming care for minors. The Supreme Court ruled in a 6-3 decision in the case of U.S. v. Skrmetti that Tennessee's SB1 ban, which bars puberty blockers and hormone therapies for transgender minors, does not violate the US Constitution and can remain in effect.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12485976

19 June 2025

U.S. Senator Ed Markey (D-MA) speaks at a rally supporting gender-affirming care at the Lutheran Church of the Reformation near the Supreme Court in Washington, D.C. on June 18, 2025 in response to the court's ruling upholding Tennessee's ban on gender-affirming care for minors. The Supreme Court ruled in a 6-3 decision in the case of U.S. v. Skrmetti that Tennessee's SB1 ban, which bars puberty blockers and hormone therapies for transgender minors, does not violate the US Constitution and can remain in effect.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12485959

19 June 2025

U.S. Senator Jeff Merkley (D-OR) speaks at a rally supporting gender-affirming care at the Lutheran Church of the Reformation near the Supreme Court in Washington, D.C. on June 18, 2025 in response to the court's ruling upholding Tennessee's ban on gender-affirming care for minors. The Supreme Court ruled in a 6-3 decision in the case of U.S. v. Skrmetti that Tennessee's SB1 ban, which bars puberty blockers and hormone therapies for transgender minors, does not violate the US Constitution and can remain in effect.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12485961

19 June 2025

U.S. Senator Jeff Merkley (D-OR) speaks at a rally supporting gender-affirming care at the Lutheran Church of the Reformation near the Supreme Court in Washington, D.C. on June 18, 2025 in response to the court's ruling upholding Tennessee's ban on gender-affirming care for minors. The Supreme Court ruled in a 6-3 decision in the case of U.S. v. Skrmetti that Tennessee's SB1 ban, which bars puberty blockers and hormone therapies for transgender minors, does not violate the US Constitution and can remain in effect.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12485963

19 June 2025

U.S. Senator Jeff Merkley (D-OR) speaks at a rally supporting gender-affirming care at the Lutheran Church of the Reformation near the Supreme Court in Washington, D.C. on June 18, 2025 in response to the court's ruling upholding Tennessee's ban on gender-affirming care for minors. The Supreme Court ruled in a 6-3 decision in the case of U.S. v. Skrmetti that Tennessee's SB1 ban, which bars puberty blockers and hormone therapies for transgender minors, does not violate the US Constitution and can remain in effect.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12485965

19 June 2025

U.S. Senator Jeff Merkley (D-OR) speaks at a rally supporting gender-affirming care at the Lutheran Church of the Reformation near the Supreme Court in Washington, D.C. on June 18, 2025 in response to the court's ruling upholding Tennessee's ban on gender-affirming care for minors. The Supreme Court ruled in a 6-3 decision in the case of U.S. v. Skrmetti that Tennessee's SB1 ban, which bars puberty blockers and hormone therapies for transgender minors, does not violate the US Constitution and can remain in effect.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12485967

19 June 2025

Deirdre Schifeling, Chief Political Advocacy Officer of the ACLU, speaks at a rally supporting gender-affirming care at the Lutheran Church of the Reformation near the Supreme Court in Washington, D.C. on June 18, 2025 in response to the court's ruling upholding Tennessee's ban on gender-affirming care for minors. The Supreme Court ruled in a 6-3 decision in the case of U.S. v. Skrmetti that Tennessee's SB1 ban, which bars puberty blockers and hormone therapies for transgender minors, does not violate the US Constitution and can remain in effect.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12485969

19 June 2025

Supporters of gender-affirming care rally at the Lutheran Church of the Reformation near the Supreme Court in Washington, D.C. on June 18, 2025 in response to the court's ruling upholding Tennessee's ban on gender-affirming care for minors. The Supreme Court ruled in a 6-3 decision in the case of U.S. v. Skrmetti that Tennessee's SB1 ban, which bars puberty blockers and hormone therapies for transgender minors, does not violate the U.S. Constitution and can remain in effect.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12485945

19 June 2025

Supporters of gender-affirming care rally at the Lutheran Church of the Reformation near the Supreme Court in Washington, D.C. on June 18, 2025 in response to the court's ruling upholding Tennessee's ban on gender-affirming care for minors. The Supreme Court ruled in a 6-3 decision in the case of U.S. v. Skrmetti that Tennessee's SB1 ban, which bars puberty blockers and hormone therapies for transgender minors, does not violate the U.S. Constitution and can remain in effect.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12485947

19 June 2025

Supporters of gender-affirming care rally at the Lutheran Church of the Reformation near the Supreme Court in Washington, D.C. on June 18, 2025 in response to the court's ruling upholding Tennessee's ban on gender-affirming care for minors. The Supreme Court ruled in a 6-3 decision in the case of U.S. v. Skrmetti that Tennessee's SB1 ban, which bars puberty blockers and hormone therapies for transgender minors, does not violate the U.S. Constitution and can remain in effect.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12485949

19 June 2025

Mariah Moore, Director of Policy and Programs at Transgender Law Center, speaks at a rally supporting gender-affirming care at the Lutheran Church of the Reformation near the Supreme Court in Washington, D.C. on June 18, 2025 in response to the court's ruling upholding Tennessee's ban on gender-affirming care for minors. The Supreme Court ruled in a 6-3 decision in the case of U.S. v. Skrmetti that Tennessee's SB1 ban, which bars puberty blockers and hormone therapies for transgender minors, does not violate the US Constitution and can remain in effect.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.